SV2007002575A - Proceso de elaboracion para tigeciclina - Google Patents

Proceso de elaboracion para tigeciclina

Info

Publication number
SV2007002575A
SV2007002575A SV2006002575A SV2006002575A SV2007002575A SV 2007002575 A SV2007002575 A SV 2007002575A SV 2006002575 A SV2006002575 A SV 2006002575A SV 2006002575 A SV2006002575 A SV 2006002575A SV 2007002575 A SV2007002575 A SV 2007002575A
Authority
SV
El Salvador
Prior art keywords
tigecicline
elaboration process
elaboration
preparation
adequate
Prior art date
Application number
SV2006002575A
Other languages
English (en)
Spanish (es)
Inventor
Gurmukh Chanana
Dominic Ventura
Richard Saunders
Mahdi B Fawzi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SV2007002575A publication Critical patent/SV2007002575A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
SV2006002575A 2005-06-16 2006-06-16 Proceso de elaboracion para tigeciclina SV2007002575A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69117305P 2005-06-16 2005-06-16

Publications (1)

Publication Number Publication Date
SV2007002575A true SV2007002575A (es) 2007-01-03

Family

ID=37111782

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2006002575A SV2007002575A (es) 2005-06-16 2006-06-16 Proceso de elaboracion para tigeciclina

Country Status (22)

Country Link
US (1) US7705168B2 (cg-RX-API-DMAC10.html)
EP (1) EP1898884A2 (cg-RX-API-DMAC10.html)
JP (3) JP2008543871A (cg-RX-API-DMAC10.html)
KR (1) KR20080024201A (cg-RX-API-DMAC10.html)
CN (1) CN101198315A (cg-RX-API-DMAC10.html)
AR (1) AR055336A1 (cg-RX-API-DMAC10.html)
AU (1) AU2006261636A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0612228A2 (cg-RX-API-DMAC10.html)
CA (1) CA2610909A1 (cg-RX-API-DMAC10.html)
CR (1) CR9594A (cg-RX-API-DMAC10.html)
EC (1) ECSP078005A (cg-RX-API-DMAC10.html)
GT (1) GT200600259A (cg-RX-API-DMAC10.html)
IL (1) IL187979A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007015960A (cg-RX-API-DMAC10.html)
NO (1) NO20076264L (cg-RX-API-DMAC10.html)
PA (1) PA8680201A1 (cg-RX-API-DMAC10.html)
PE (1) PE20070072A1 (cg-RX-API-DMAC10.html)
RU (1) RU2007145595A (cg-RX-API-DMAC10.html)
SV (1) SV2007002575A (cg-RX-API-DMAC10.html)
TW (1) TW200716203A (cg-RX-API-DMAC10.html)
WO (1) WO2006138641A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200710906B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007713A2 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Isolation of tetracycline derivatives
PT2016045E (pt) * 2006-04-24 2015-02-05 Teva Pharma Forma cristalina de tigeciclina e processos para a sua preparação
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2086926A2 (en) * 2006-11-29 2009-08-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of tigecycline and processes for preparation thereof
MX2008009727A (es) * 2006-11-30 2009-01-09 Teva Pharma Procesos para la preparacion de 9-haloacetamidominociclinas.
WO2008106234A1 (en) * 2007-03-01 2008-09-04 Teva Pharmaceutical Industries Ltd. Processes for purification of tigecycline
WO2009052152A2 (en) * 2007-10-16 2009-04-23 Wyeth Tigecycline and methods of preparing intermediates
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
EP2406213A1 (en) 2009-03-12 2012-01-18 Wyeth LLC Nitration of tetracyclines
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
IN2013MU01127A (cg-RX-API-DMAC10.html) 2013-03-26 2015-05-01 Astron Res Ltd
WO2014167575A2 (en) 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
CN103202814A (zh) * 2013-04-23 2013-07-17 成都百裕科技制药有限公司 一种注射用替加环素的制备方法
CN105924367B (zh) * 2016-04-18 2017-12-29 镇江高海生物药业有限公司 多西环素一水物的有关物质及其分析检测方法
US20190233153A1 (en) * 2018-01-26 2019-08-01 AL Pharma, Inc. Manufacturing and packaging of a sterile drug product
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN116531322A (zh) * 2023-06-27 2023-08-04 遂成药业股份有限公司 一种高稳定性呋塞米注射液及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026248A (en) * 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US6660267B1 (en) * 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
AU2003265241A1 (en) * 2002-05-23 2003-12-12 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
CN101039679A (zh) * 2004-10-28 2007-09-19 惠氏公司 替加环素和地高辛的共投与
EP1858488B2 (en) * 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina

Also Published As

Publication number Publication date
AR055336A1 (es) 2007-08-22
EP1898884A2 (en) 2008-03-19
JP2009191083A (ja) 2009-08-27
WO2006138641A3 (en) 2007-05-18
GT200600259A (es) 2007-05-08
CR9594A (es) 2008-03-07
JP2008543871A (ja) 2008-12-04
AU2006261636A1 (en) 2006-12-28
RU2007145595A (ru) 2009-07-27
CN101198315A (zh) 2008-06-11
KR20080024201A (ko) 2008-03-17
BRPI0612228A2 (pt) 2011-03-29
WO2006138641A2 (en) 2006-12-28
CA2610909A1 (en) 2006-12-28
JP2010024252A (ja) 2010-02-04
US7705168B2 (en) 2010-04-27
MX2007015960A (es) 2008-03-06
TW200716203A (en) 2007-05-01
ZA200710906B (en) 2009-03-25
NO20076264L (no) 2008-03-10
PE20070072A1 (es) 2007-02-25
IL187979A0 (en) 2008-03-20
PA8680201A1 (es) 2007-01-17
ECSP078005A (es) 2008-01-23
US20070026080A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
PA8680201A1 (es) Proceso de elaboración para tigeciclina
LTPA2020536I1 (lt) Nauji anti-CD38 antikūnai, skirti vėžio gydymui
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
SG171617A1 (en) Therapeutic compounds
LTPA2016032I1 (lt) Hipoglikeminių agentų skyrimo būdai
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA200802213A1 (ru) Способы лечения заболеваний крови
HUE042328T2 (hu) Eljárás elágazó szénhidrogén komponens elõállítására
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
CY1111793T1 (el) Μυκητοκτονες συνθεσεις
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
MY160392A (en) Triptolide prodrugs
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
TNSN08244A1 (en) Process for the preparation of ferri-succinylcasein
SG148179A1 (en) Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
HUE043068T2 (hu) Eljárás elágazó láncú szénhidrogén komponens elõállítására
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
EP2083003A4 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLORBUTANE
EA200800324A1 (ru) Новый способ получения солей тиотропия
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина